Clinical Trials Logo

Dydrogesterone clinical trials

View clinical trials related to Dydrogesterone.

Filter by:
  • None
  • Page 1

NCT ID: NCT04758871 Completed - Infertility, Female Clinical Trials

Oral Versus Vaginal Progesterone for Luteal Phase Supplementation in Frozen Embryo Transfer Cycles

REMODEL
Start date: October 1, 2021
Phase: Phase 4
Study type: Interventional

To investigate the efficacy of dydrogesterone 30 mg compared to micronized vaginal progesterone 800 mg daily for luteal phase support in hormone replacement therapy frozen embryo transfer cycles, as confirmed by visualization of fetal heart activity by pelvic ultrasound assessment of ongoing pregnancy at 12 weeks of gestation.

NCT ID: NCT04124913 Recruiting - Infertility, Female Clinical Trials

Oral Dydrogesterone vs. Micronized Vaginal Progesterone for Luteal Phase Support in Frozen-thawed Embryo Transfer Cycles

Start date: January 2, 2019
Phase: Phase 4
Study type: Interventional

The aim of this randomized controlled trial is to compare the efficacy of oral dydrogesterone vs. micronized vaginal progesterone for luteal phase support in frozen-thawed embryo transfer cycles.

NCT ID: NCT03677336 Completed - Infertility Clinical Trials

Oral Dydrogesterone (OD) Versus Micronized Vaginal Progesterone (MVP) for Luteal Phase Support (LPS) in IVF/ICSI

Start date: May 1, 2019
Phase: Phase 4
Study type: Interventional

Female inability to conceive a child. The purpose of this prospective randomized, double-blinded, double dummy, two-arm cross-over study is to investigate the difference on histological, transcriptional and immunological level in endometrium between 3x10mg Dydrogesterone oral tablets and 3x200 mg Micronized progesterone intravaginal capsules for the luteal support in egg cell donors. Beside that, the pharmacokinetics, the impact on the peripheral immunology (by blood sampling) and the microbiota (by genital swabs) will be investigated.

NCT ID: NCT02029144 Completed - Clinical trials for Abnormal Uterine Bleeding

Observational Study of Dydrogesterone in Cycle Regularization

Start date: December 2013
Phase: N/A
Study type: Observational

Dydrogesterone has been widely used worldwide for various gynecological and obstetric indications: - Dydrogesterone is effective in cycle regulation treatment. - Dydrogesterone is recognized as none interference to hypothalamus pituitary ovary (HPO) axis in the recommended dosage. - Dydrogesterone might have non-negative effect on glucose and lipid metabolic.